ARCHIVES

CTAC Discussion, Group Chairs Comment

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

NCI Expected of Fund Cancer Education Grants In Fiscal 1986; Final Fate to Be Decided This Week

March 7, 1986

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

November issue of Business & Regulatory Report included.

November 28, 2003

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999